Taipei, Taiwan

Chiao-Chu Ku

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiao-Chu Ku. Retrieved from https://idiyas.com/inventor/chiao-chu-ku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chiao-Chu Ku in Catalysis

Introduction

Chiao-Chu Ku is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of catalysis, particularly in the synthesis of pharmaceuticals. His innovative work has led to advancements that enhance the efficiency and economic viability of drug production.

Latest Patents

Chiao-Chu Ku holds a patent for "Catalysts and their uses in one-pot diastereoselective synthesis of remdesivir." This patent discloses novel catalysts that facilitate the production of remdesivir in a one-pot manner. The process involves creating a diastereomerically enriched form of an intermediate, which, after acidic hydrolysis, yields the desired remdesivir. The disclosed catalysts improve the preparation process of remdesivir by eliminating the need to separate one of the enantiomers while minimizing the formation of undesired isomers. This innovation offers significant economic advantages for commercial-scale operations. He has 1 patent to his name.

Career Highlights

Chiao-Chu Ku is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in the field of chemistry.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Chiao-Chu Ku's innovative work in catalysis, particularly in the synthesis of remdesivir, showcases his significant contributions to the field. His advancements not only enhance the efficiency of pharmaceutical production but also provide economic benefits for commercial applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…